PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.23%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-7.26%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-9.56%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-11.12%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-12.95%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-12.96%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-13.15%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.11%
Share count expansion well above QCOM's 0.18%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
No Data
No Data available this quarter, please select a different quarter.
0.07%
Maintaining or increasing dividends while QCOM cut them. John Neff might see a strong edge in shareholder returns.
-43.19%
Negative OCF growth while QCOM is at 114.04%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-83.44%
Negative FCF growth while QCOM is at 232.14%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
85.25%
10Y revenue/share CAGR at 50-75% of QCOM's 139.51%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
25.26%
5Y revenue/share CAGR under 50% of QCOM's 105.29%. Michael Burry would suspect a significant competitive gap or product weakness.
35.02%
3Y revenue/share CAGR under 50% of QCOM's 90.04%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
293.27%
10Y OCF/share CAGR above 1.5x QCOM's 138.69%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
13.06%
Below 50% of QCOM's 131.23%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
39.92%
3Y OCF/share CAGR under 50% of QCOM's 182.26%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
475.86%
Net income/share CAGR above 1.5x QCOM's 78.61% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
35.51%
Below 50% of QCOM's 149.42%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
49.34%
Below 50% of QCOM's 146.36%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
69.87%
Positive growth while QCOM is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
55.24%
5Y equity/share CAGR above 1.5x QCOM's 3.50%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
102.31%
Below 50% of QCOM's 324.97%. Michael Burry suspects a serious short-term disadvantage in building book value.
491.84%
10Y dividend/share CAGR above 1.5x QCOM's 199.65%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
99.55%
5Y dividend/share CAGR above 1.5x QCOM's 31.33%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
37.31%
3Y dividend/share CAGR above 1.5x QCOM's 20.92%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-0.95%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
19.26%
Inventory growth well above QCOM's 9.32%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
7.40%
Asset growth above 1.5x QCOM's 2.04%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.45%
Similar to QCOM's 4.24%. Walter Schloss finds parallel capital usage or profit distribution strategies.
11.53%
Debt growth far above QCOM's 9.01%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
4.84%
R&D growth drastically higher vs. QCOM's 3.35%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
10.49%
We expand SG&A while QCOM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.